Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Balancing disruption: Proposal might ban big parts of KC from short-term rentals
Feb. 22 update: After a robust, 40-minute conversation Thursday, the full Kansas City Council voted 7-4 to pass a proposed ordinance that would prohibit short-term rentals in residential neighborhoods zoned as R-7.5 and R-10. Voting yes: council members Scott Wagner, Heather Hall, Dan Fowler, Lee Barnes, Jr., Alissia Canady, Scott Taylor and Kevin McManus. Voting…
MADE’s Heartbreak Kids splits design silence on tension with Charlie Hustle
Streetwear is about making a statement, Vu Radley said, and the Heartbreak Kids collection says more than words alone could express. “It’s an attitude. Pushing out statements without censoring yourself,” said Radley, co-founder and creative director for MADE Urban Apparel. “We say it how it is in our designs.” For the Heartbreak Kids capsule, which…
Want a globally competitive KC? Look beyond smart city ‘bling,’ Digi.City founder says
The U.S. has a lot of catching up to do, said Chelsea Collier, founder of Digi.City. It’s not quite doomsday, but Collier wanted to express a sense of urgency, she said Friday during a Smart Metro Summit at Plexpod Westport Commons. Cities need to get smart — fast — or the United States will continue to…
Techstars’ Lesa Mitchell: Non-sexy sectors are ripe for disruption
Editor’s note: The opinions expressed in this commentary are the author’s alone. In the process of looking for a new crop of companies to invest in on behalf of Techstars Kansas City, I thought I should highlight the type of companies I think are undervalued and critical to our economy. In 2017 we invested in…